These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 23937581)
1. Effect of binder liquid type on spherical crystallization. Maghsoodi M; Hajipour A Drug Dev Ind Pharm; 2014 Nov; 40(11):1468-75. PubMed ID: 23937581 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of physico-mechanical properties of drug-excipients agglomerates obtained by crystallization. Maghsoodi M; Tajalli Bakhsh AS Pharm Dev Technol; 2011 Jun; 16(3):243-9. PubMed ID: 20175665 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the effect of some additives on the efficiency of binder liquid in wet agglomeration of crystals. Maghsoodi M; Nabizadeh H; Nokhodchi A Pharm Dev Technol; 2017 Sep; 22(6):827-835. PubMed ID: 27387408 [TBL] [Abstract][Full Text] [Related]
4. Agglomeration of celecoxib by quasi-emulsion solvent diffusion method without stabilizer: effect of good solvent. Maghsoodi M; Nokhodchi A Pharm Dev Technol; 2018 Dec; 23(10):1037-1046. PubMed ID: 27937049 [TBL] [Abstract][Full Text] [Related]
5. Effect of process variables on physicomechanical properties of the agglomerates obtained by spherical crystallization technique. Maghsoodi M Pharm Dev Technol; 2011 Oct; 16(5):474-82. PubMed ID: 20557281 [TBL] [Abstract][Full Text] [Related]
7. On the mechanisms of formation of spherical agglomerates. Thati J; Rasmuson AC Eur J Pharm Sci; 2011 Mar; 42(4):365-79. PubMed ID: 21216285 [TBL] [Abstract][Full Text] [Related]
8. Spherical crystallization of benzoic acid. Katta J; Rasmuson AC Int J Pharm; 2008 Feb; 348(1-2):61-9. PubMed ID: 17765414 [TBL] [Abstract][Full Text] [Related]
9. On the mechanism of agglomeration in suspension. Maghsoodi M; Derakhshandeh K; Yari Z Adv Pharm Bull; 2012; 2(1):25-30. PubMed ID: 24312767 [TBL] [Abstract][Full Text] [Related]
10. Effect of temperature on wet agglomeration of crystals. Maghsoodi M; Yari Z Iran J Basic Med Sci; 2014 May; 17(5):344-50. PubMed ID: 24967063 [TBL] [Abstract][Full Text] [Related]
11. Spherical agglomeration to improve dissolution and micromeritic properties of an anticancer drug, Bicalutamide. Dalvadi H; Parmar K; Yadav S Drug Dev Ind Pharm; 2019 Jun; 45(6):968-980. PubMed ID: 30784326 [TBL] [Abstract][Full Text] [Related]
12. Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique. Maghsoodi M; Taghizadeh O; Martin GP; Nokhodchi A Int J Pharm; 2008 Mar; 351(1-2):45-54. PubMed ID: 17980983 [TBL] [Abstract][Full Text] [Related]
14. An investigation into the effect of formulation variables and process parameters on characteristics of granules obtained by in situ fluidized hot melt granulation. Mašić I; Ilić I; Dreu R; Ibrić S; Parojčić J; Durić Z Int J Pharm; 2012 Feb; 423(2):202-12. PubMed ID: 22197773 [TBL] [Abstract][Full Text] [Related]
15. Compression shear strength and tableting behavior of microcrystalline cellulose agglomerates modulated by a solution binder (polyethylene glycol). Nicklasson F; Alderborn G Pharm Res; 2001 Jun; 18(6):873-7. PubMed ID: 11474794 [TBL] [Abstract][Full Text] [Related]
16. Improving flowability and reducing storage agglomeration of metformin hydrochloride through QESD crystallization. Hansen J; Kleinebudde P Eur J Pharm Biopharm; 2021 Feb; 159():170-176. PubMed ID: 33460735 [TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of agglomerated crystals by crystallo-co-agglomeration: an integrated approach of principal component analysis and Box-Behnken experimental design. Garala KC; Patel JM; Dhingani AP; Dharamsi AT Int J Pharm; 2013 Aug; 452(1-2):135-56. PubMed ID: 23684660 [TBL] [Abstract][Full Text] [Related]
18. Spherical crystallization of mebendazole to improve processability. Kumar S; Chawla G; Bansal AK Pharm Dev Technol; 2008; 13(6):559-68. PubMed ID: 18720249 [TBL] [Abstract][Full Text] [Related]
19. Droplet-Templated Antisolvent Spherical Crystallization of Hydrophilic and Hydrophobic Drugs with an in situ Formed Binder. Gu T; Yeap EWQ; Cao Z; Ng DZL; Ren Y; Chen R; Khan SA; Hatton TA Adv Healthc Mater; 2018 Feb; 7(3):. PubMed ID: 28961377 [TBL] [Abstract][Full Text] [Related]
20. Preparation of sustained release matrix pellets by melt agglomeration in the fluidized bed: influence of formulation variables and modelling of agglomerate growth. Pauli-Bruns A; Knop K; Lippold BC Eur J Pharm Biopharm; 2010 Mar; 74(3):503-12. PubMed ID: 20026401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]